Arcosa, Inc. Files 8-K for Regulatory Disclosure
Ticker: ACA · Form: 8-K · Filed: Aug 12, 2024 · CIK: 1739445
| Field | Detail |
|---|---|
| Company | Arcosa, INC. (ACA) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $600 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Arcosa filed a routine 8-K on Aug 12, nothing major to see here.
AI Summary
Arcosa, Inc. filed an 8-K on August 12, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for this form type.
Why It Matters
This filing serves as a standard notification to the SEC regarding regulatory disclosures and financial statements, ensuring transparency for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for regulatory disclosure and does not contain any new material information that would impact risk.
Key Players & Entities
- Arcosa, Inc. (company) — Registrant
- August 12, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 500 N. Akard Street, Suite 400 Dallas, Texas 75201 (address) — Principal Executive Offices
- 972-942-6500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Arcosa, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as indicated in the filing.
On what date was this 8-K filed by Arcosa, Inc.?
This 8-K filing was made on August 12, 2024.
What is the state of incorporation for Arcosa, Inc.?
Arcosa, Inc. is incorporated in Delaware.
What is the address of Arcosa, Inc.'s principal executive offices?
The address of Arcosa, Inc.'s principal executive offices is 500 N. Akard Street, Suite 400, Dallas, Texas 75201.
Does this filing contain specific financial results or new material events?
Based on the provided text, this filing is for regulatory disclosure and financial statements/exhibits, and does not appear to contain specific new financial results or material events beyond the standard reporting requirements.
Filing Stats: 577 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-08-12 07:33:59
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) ACA New York Stock Exchange
- $600 million — s proposed offering (the "Offering") of $600 million in aggregate principal amount of senior
Filing Documents
- aca-20240812.htm (8-K) — 27KB
- exh991pressrelease-seniorn.htm (EX-99.1) — 18KB
- aca-20240812_g1.jpg (GRAPHIC) — 25KB
- image2.jpg (GRAPHIC) — 25KB
- 0001739445-24-000121.txt ( ) — 281KB
- aca-20240812.xsd (EX-101.SCH) — 2KB
- aca-20240812_def.xml (EX-101.DEF) — 14KB
- aca-20240812_lab.xml (EX-101.LAB) — 25KB
- aca-20240812_pre.xml (EX-101.PRE) — 15KB
- aca-20240812_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 12, 2024, Arcosa issued a press release announcing its proposed offering (the "Offering") of $600 million in aggregate principal amount of senior notes due 2032 (the "Notes"). A copy of the press release announcing the Offering is attached as Exhibit 99.1 to this report on Form 8-K and is incorporated by reference herein. The information in Item 7.01 of this report (including Exhibit 99.1) is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing. Additionally, the submission of this Item 7.01 is not an admission of the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD. This report does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Arcosa, Inc. Press Release, dated August 12, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Arcosa, Inc. (Registrant) August 12, 2024 By: /s/ Gail M. Peck Name: Gail M. Peck Title: Chief Financial Officer